Cognitive behavioral therapy program for cannabis use cessation in first-episode psychosis patients: study protocol for a randomized controlled trial.

Poor medication adherence and risk of relapse associated with continued cannabis use in patients with first-episode psychosis: a prospective analysis. Lancet Psychiatry (2017) 0.80

The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull (1987) 51.07

A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry (1978) 25.54

The assessment of anxiety states by rating. Br J Med Psychol (1959) 24.58

Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care (1986) 22.65

Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol (1967) 22.39

Assessment of insight in psychosis. Am J Psychiatry (1993) 3.48

Cannabis use and earlier onset of psychosis: a systematic meta-analysis. Arch Gen Psychiatry (2011) 2.04

Reduced cortical cannabinoid 1 receptor messenger RNA and protein expression in schizophrenia. Arch Gen Psychiatry (2008) 1.64

[Descriptive study of patient compliance in pharmacologic antihypertensive treatment and validation of the Morisky and Green test]. Aten Primaria (1992) 1.61

Cerebrospinal anandamide levels are elevated in acute schizophrenia and are inversely correlated with psychotic symptoms. Neuropsychopharmacology (2004) 1.55

Validity and reliability of the Functioning Assessment Short Test (FAST) in bipolar disorder. Clin Pract Epidemiol Ment Health (2007) 1.52

Endocannabinoid signalling in the blood of patients with schizophrenia. Lipids Health Dis (2003) 1.29

Daily use, especially of high-potency cannabis, drives the earlier onset of psychosis in cannabis users. Schizophr Bull (2013) 1.29

Cannabis and first-episode psychosis: different long-term outcomes depending on continued or discontinued use. Schizophr Bull (2009) 1.17

The impact of substance use disorders on clinical outcome in 643 patients with first-episode psychosis. Acta Psychiatr Scand (2005) 1.13

[Validation of positive and negative symptom scale (PANSS) in a sample of Spanish schizophrenic patients]. Actas Luso Esp Neurol Psiquiatr Cienc Afines (1995) 1.11

Randomized controlled trial of a cannabis-focused intervention for young people with first-episode psychosis. Acta Psychiatr Scand (2006) 1.11

Anandamide levels in cerebrospinal fluid of first-episode schizophrenic patients: impact of cannabis use. Schizophr Res (2007) 1.09

Brain cannabinoid CB2 receptor in schizophrenia. Biol Psychiatry (2009) 1.07

Cannabis use and brain structural alterations in first episode schizophrenia--a region of interest, voxel based morphometric study. Schizophr Res (2008) 1.07

[Validation of the Spanish versions of the Montgomery-Asberg depression and Hamilton anxiety rating scales]. Med Clin (Barc) (2002) 1.04

Reliability and validity of the German version of the European Addiction Severity Index (EuropASI). J Stud Alcohol (2000) 1.04

[Validation of the Castillian version of the Hamilton Rating Scale for Depression]. Actas Luso Esp Neurol Psiquiatr Cienc Afines (1986) 1.04

Cannabinoid receptor 1 gene polymorphisms and marijuana misuse interactions on white matter and cognitive deficits in schizophrenia. Schizophr Res (2011) 1.01

Age of onset of cannabis use is associated with age of onset of high-risk symptoms for psychosis. Can J Psychiatry (2010) 1.00

[Spanish version of a scale for the assessment of mania: validity and reliability of the Young Mania Rating Scale]. Med Clin (Barc) (2002) 0.99

Impact of cannabis and other drugs on age at onset of psychosis. J Clin Psychiatry (2008) 0.98

Cannabis use and first-episode psychosis: relationship with manic and psychotic symptoms, and with age at presentation. Psychol Med (2013) 0.97

Cannabis use in children and adolescents with first episode psychosis: influence on psychopathology and short-term outcome (CAFEPS study). Schizophr Res (2009) 0.95

Effect of cannabis use on the course of schizophrenia in male patients: a prospective cohort study. Schizophr Res (2012) 0.93

Cannabis use and age at onset of symptoms in subjects at clinical high risk for psychosis. Acta Psychiatr Scand (2011) 0.93

Regulatory role of cannabinoid receptor 1 in stress-induced excitotoxicity and neuroinflammation. Neuropsychopharmacology (2010) 0.92

Correlations and agreement between delta-9-tetrahydrocannabinol (THC) in blood plasma and timeline follow-back (TLFB)-assisted self-reported use of cannabis of patients with cannabis use disorder and psychotic illness attending the CapOpus randomized clinical trial. Addiction (2012) 0.88

A multi-center, randomized controlled trial of a group psychological intervention for psychosis with comorbid cannabis dependence over the early course of illness. Schizophr Res (2012) 0.85

Change in cannabis use, clinical symptoms and social functioning among patients with first-episode psychosis: a 5-year follow-up study of patients in the OPUS trial. Psychol Med (2013) 0.85

Characterizing the longitudinal patterns of substance use among individuals diagnosed with serious mental illness after psychiatric hospitalization. Addiction (2013) 0.85

Cannabis use in patients at clinical high risk of psychosis: impact on prodromal symptoms and transition to psychosis. Curr Pharm Des (2012) 0.85

Continued cannabis use and outcome in first-episode psychosis: data from a randomized, open-label, controlled trial. J Clin Psychiatry (2012) 0.84

Prevalence and impact of cannabis use disorders in adolescents with early onset first episode psychosis. Eur Psychiatry (2011) 0.84

The Cannabis Use Problems Identification Test (CUPIT): development, reliability, concurrent and predictive validity among adolescents and adults. Addiction (2010) 0.84

Motivational intervention to reduce cannabis use in young people with psychosis: a randomized controlled trial. Psychother Psychosom (2011) 0.83

[Spanish adaptation of the Scale to Asses Unawareness of Mental Disorder (SUMD)]. Actas Esp Psiquiatr (2008) 0.83

The impact of cannabis use on age of onset and clinical characteristics in first-episode psychotic patients. Data from the Psychosis Incident Cohort Outcome Study (PICOS). J Psychiatr Res (2013) 0.83

Cannabis use, gender and age of onset of schizophrenia: data from the ÆSOP study. Psychiatry Res (2014) 0.82

A phase-specific psychological therapy for people with problematic cannabis use following a first episode of psychosis: a randomized controlled trial. Psychol Med (2014) 0.81

Social functioning trajectories of young first-episode psychosis patients with and without cannabis misuse: a 30-month follow-up study. PLoS One (2015) 0.78

Adolescent Initiation of Cannabis Use and Early-Onset Psychosis. Subst Abus (2015) 0.78

[Cognitive behavior therapy after first-episodes psychosis]. Encephale (2013) 0.77

Medication adherence mediates the impact of sustained cannabis use on symptom levels in first-episode psychosis. Schizophr Res (2012) 0.76